EyePoint, Inc. (EYPT) vs X4 Pharmaceuticals, Inc. (XFOR)
- EyePoint, Inc. EYPT 3.00 −4.46%
- X4 Pharmaceuticals, Inc. XFOR 2.59 −1.89%
EyePoint, Inc. and X4 Pharmaceuticals, Inc. are both Biotechnology companies. EyePoint, Inc. and X4 Pharmaceuticals, Inc. are of similar size ($270.7M and $261.8M). X4 Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −51.7% against −94.6%. X4 Pharmaceuticals, Inc. has the higher net margin (−568.8% vs −10,998.7%) and the lower return on invested capital (−226.6% vs 0.00%). Across the 17 metrics below, X4 Pharmaceuticals, Inc. leads on 13 and EyePoint, Inc. on 4.
Valuation
Profitability
| Metric | EYPT | XFOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 41.75% | 81.51% | 65.16% |
| Operating margin | (11,369.30%) | (554.71%) | 0.00% |
| Net margin | (10,998.67%) | (568.80%) | 0.00% |
| Free cash flow margin | (9,724.68%) | (559.95%) | 0.00% |
| Return on equity | (148.70%) | (113.08%) | (56.36%) |
| Return on assets | (115.86%) | (50.32%) | (48.04%) |
| Return on invested capital | 0.00% | (226.62%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack